Glaucoma itself, in its most common adult forms, does not directly make your eyes water. The connection between glaucoma and watery eyes runs through several less obvious pathways: the medications used to treat glaucoma are a major cause of tearing and ocular surface irritation, certain rarer types of glaucoma do trigger watering as a direct symptom, and the relationship between the two can create a frustrating cycle where treatment side effects discourage the very compliance needed to protect your vision.
When Glaucoma Itself Causes Tearing
Most adults diagnosed with open-angle glaucoma, the type that accounts for the vast majority of cases, will not experience watery eyes from the disease alone. Open-angle glaucoma is famously silent in its early stages, causing no pain, no redness, and no obvious symptoms until peripheral vision starts to narrow. But there are two important exceptions where the glaucoma itself is the direct culprit behind tearing.
The first is congenital glaucoma, a condition present from birth or early infancy. In babies and very young children, elevated eye pressure causes the cornea to swell and stretch, which is painful and irritating. The classic presentation includes tearing (called epiphora), light sensitivity, and involuntary squeezing of the eyelids.1PubMed. Primary congenital glaucoma Parents often notice that their infant’s eyes are persistently watery and that the child turns away from bright light. That said, the full combination of tearing plus light sensitivity appears in only about a third of cases at the time parents first seek medical attention, so absence of all the classic signs does not rule out the diagnosis.2Pediatrics. Signs and Symptoms in the Presentation of Primary Infantile Glaucoma In infants, persistent watery eyes are worth mentioning to a pediatrician because, while a blocked tear duct is the more common explanation, congenital glaucoma is the one you do not want to miss.
The second exception is acute angle-closure glaucoma, an emergency in which eye pressure spikes rapidly. When pressure climbs fast, the cornea becomes waterlogged, vision blurs, and the patient may see halos around lights.3BMJ. Glaucoma—1: Diagnosis The eye becomes red and intensely painful, and reflex tearing is part of the body’s response to the sudden corneal swelling. Unlike the slow, painless progression of open-angle glaucoma, angle-closure attacks announce themselves with dramatic symptoms that typically send people to an emergency room.
How Glaucoma Eye Drops Trigger Watery Eyes
For most adults living with glaucoma, watery eyes are not caused by the disease but by the drops they use every day to control it. Eye drops remain the first-line treatment for lowering intraocular pressure, and many of them contain a preservative called benzalkonium chloride, or BAK. BAK is effective at keeping bottles sterile, but it is also toxic to the delicate surface of the eye with repeated exposure.
BAK disrupts the lipid layer of the tear film, the thin oily coating that sits on top of your tears and prevents them from evaporating too quickly. Laboratory work shows that in the presence of BAK, this lipid layer collapses at far lower pressures than it normally would, losing its structure and its ability to spread back into place after a blink.4PubMed Central. Stability and Compressibility of Tear Film Lipid Layer: Impact of Benzalkonium Chloride Presence When the protective lipid layer breaks down, tears evaporate faster, the surface of the eye becomes irritated, and the lacrimal gland compensates by producing a flood of watery, low-quality tears. This is the same paradox seen in ordinary dry eye disease: the eyes feel dry and gritty, yet they water constantly because the reflex tearing system kicks in to address the irritation.
A randomized clinical study comparing BAK-containing latanoprost (a common prostaglandin drop) with preservative-free bimatoprost found that the BAK-containing formulation was linked to decreased tear secretion and signs of tear-film instability.5PubMed. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost In practice, this means the eyes make fewer of the stable, lubricating tears they need, and more of the reactive, watery tears that run down your cheeks but do little to protect the cornea.
Allergic Reactions to Glaucoma Medications
Beyond straightforward preservative toxicity, some glaucoma drugs provoke actual allergic responses. Brimonidine, an alpha-agonist drop widely prescribed for glaucoma, is a well-known offender. In one study of 140 patients on brimonidine, roughly one in four developed an allergic reaction. The most common forms were contact dermatoconjunctivitis and follicular conjunctivitis, both of which involve redness, itching, eyelid swelling, and, predictably, watery eyes.6PubMed. Allergic reactions to brimonidine in patients treated for glaucoma
The tricky part is that these reactions often develop weeks or months after starting the medication, not right away. A patient who has been using brimonidine without trouble for several months may suddenly find their eyes watering, red, and itchy, and may not immediately connect it to a drug they have been tolerating fine. If you are on a glaucoma drop and develop new-onset tearing alongside redness or eyelid irritation, an allergic reaction to the medication itself is a real possibility that is worth raising with your eye doctor.
Long-Term Drops and Drainage Blockage
There is a more mechanical way that years of glaucoma drops can lead to chronically watery eyes: they can physically scar and narrow the tiny drainage channels that carry tears from the eye surface into the nose. Tears normally drain through two small openings at the inner corner of each eye (the puncta) and then through narrow tubes called canaliculi into the nasal cavity. When these structures become inflamed or scarred shut, tears have nowhere to go and spill over the eyelid.
Multiple topical glaucoma medications, including timolol, pilocarpine, and others, have been associated with canalicular or punctal occlusion. The exposure duration before obstruction develops varies widely, from weeks to many years of use.7PubMed. Lacrimal canalicular obstruction associated with topical ocular medication Once the drainage pathway is scarred, the problem persists even after stopping the offending drops, and some patients ultimately need a surgical procedure to restore tear drainage. This is one of the less-discussed consequences of long-term topical glaucoma therapy, and it is distinct from the tear-film instability caused by BAK. A patient can have both at the same time: irritated eyes producing excess reflex tears and blocked drainage channels preventing those tears from clearing normally.
Meibomian Gland Dysfunction in Glaucoma Patients
The eyelids contain dozens of tiny oil-producing glands called meibomian glands, which are responsible for that protective lipid layer we discussed earlier. Long-term glaucoma drop use appears to damage these glands at high rates. One study of early middle-aged patients found meibomian gland dysfunction in about 82% of those using topical glaucoma medications, compared with roughly 53% in a control group not using the drops.8Ovid. Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications The average duration of drop use in that group was just over two years.
Meibomian gland dysfunction creates the same downstream problem as BAK-damaged tear film: the oily layer thins out, tears evaporate too quickly, the eye surface dries, and reflex tearing kicks in. The difference is that meibomian gland damage can be more structural and harder to reverse. When the glands atrophy from prolonged inflammation, they may not bounce back even after a medication change. This is why eye care specialists increasingly advocate for monitoring the ocular surface early in glaucoma treatment, rather than waiting for symptoms to become severe.
How Watery Eyes Undermine Glaucoma Treatment
The relationship between glaucoma and watery eyes is not just a comfort issue. It feeds back into treatment effectiveness in two important ways.
First, tearing physically washes medication out of the eye before it can be absorbed. Research on topical drug absorption has shown that profuse tearing significantly and rapidly reduces how much of the medication reaches the anterior chamber of the eye, where it needs to act.9PubMed Central. Absorption of fluorescein given under the upper lid If your eyes water heavily every time you instill a drop, a meaningful portion of the active drug may be lost before it can lower your pressure. This is especially relevant for younger patients, who tend to produce more reflex tears.
Second, and arguably more consequential, ocular surface symptoms drive patients to stop using their drops consistently. In a study of veterans with glaucoma, patients who reported dry eye symptoms were far less likely to be compliant with their medication regimen. Only about 63% of those with dry eye symptoms were compliant, compared with 89% of those without symptoms. Dry eye symptoms carried a roughly sixfold increased risk of noncompliance even after accounting for other factors like anxiety and depression.10PubMed Central. Barriers To Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders Since glaucoma is a disease that progresses silently, patients who skip drops because the drops make their eyes burn, water, and sting may not realize they are losing vision until the damage is advanced. The side effects of treatment can, in a roundabout way, become a cause of disease progression.
Preservative-Free Drops and Other Ways to Reduce the Problem
The most straightforward step for a glaucoma patient dealing with watery, irritated eyes is to ask about preservative-free formulations of their medication. These have become increasingly available, and studies consistently show that patients who switch from BAK-preserved drops to preservative-free versions report improvement in ocular surface symptoms.11PubMed Central. Ocular Surface Disease and Glaucoma Medications: A Clinical Approach The active drug remains the same; what changes is the removal of the preservative that was damaging the tear film and irritating the surface tissues.
Beyond switching formulations, reducing the total number of drops a patient uses each day can help. Every additional bottle in the regimen means more preservative exposure and more disruption of the ocular surface. This is one of the reasons eye care professionals have become more interested in laser procedures and minimally invasive surgical approaches as alternatives or supplements to drops. Selective laser trabeculoplasty (SLT), for example, can be used as a first-line treatment instead of drops. One study found that patients who underwent SLT had significantly less punctate keratitis (tiny areas of corneal surface damage) afterward compared with before, when they were using drops. They also reported fewer side effects, fewer changes in the appearance of their eyes, and greater confidence in their therapy.12PubMed Central. Quality of life in glaucoma patients after selective laser trabeculoplasty
Minimally invasive glaucoma surgery (MIGS) procedures offer another route to reducing drop burden. These small implants or micro-incisions lower eye pressure through internal drainage pathways, and because they can reduce or eliminate the need for daily drops, they often lead to improved ocular surface health as well. Clinical reviews have noted that MIGS is associated with both reduced medication use and improved signs and symptoms on the eye surface.13PubMed Central. Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat For patients caught in the cycle of drops causing surface disease causing noncompliance causing disease progression, these approaches can break the loop.
When to Bring Up Watery Eyes With Your Doctor
Many glaucoma patients assume that watery, irritated eyes are just part of the deal and do not mention the problem at their appointments. Doctors, meanwhile, tend to focus on intraocular pressure numbers and optic nerve health, and may not ask about surface symptoms unless the patient raises them. This disconnect is well documented in the ophthalmology literature. The result is that treatable ocular surface disease goes unaddressed for months or years, quietly eroding both quality of life and medication adherence.
A few situations should prompt a conversation sooner rather than later. Persistent tearing that starts or worsens after beginning a new glaucoma drop suggests preservative toxicity or an allergic reaction, both of which can be addressed by switching medications. Tearing accompanied by redness, itching, or swollen eyelids points more specifically toward allergy. Tearing that persists even after stopping drops may indicate mechanical blockage of the tear drainage system, which requires a different workup. And in an infant or young child, tearing combined with light sensitivity or an unusually large-looking eye warrants urgent evaluation for congenital glaucoma.
None of these scenarios requires you to choose between protecting your vision and keeping your eyes comfortable. The range of available treatments, from preservative-free drops to laser procedures to surgical options, is wider than it was even a decade ago. But the first step is recognizing that watery eyes in a glaucoma patient are not a cosmetic nuisance. They are a clinical signal that something about the treatment regimen may need to change.
Dry Eye and Watery Eye Are Not Opposites
One of the most persistent sources of confusion around this topic is the assumption that “dry eye” and “watery eye” are opposite problems requiring opposite solutions. They are not. In the context of glaucoma treatment, they are usually the same problem at different stages of the same process. The surface of the eye dries out because the tear film is unstable, the cornea sends distress signals through the trigeminal nerve, and the lacrimal gland responds by flooding the eye with watery reflex tears. These reflex tears lack the mucin and lipid components that make tears actually functional, so they wash over the surface without providing lasting relief, and the cycle repeats.
This is why a glaucoma patient can truthfully report both “my eyes feel dry” and “my eyes won’t stop watering” in the same appointment, and why the treatment for both complaints is often the same: stabilize the tear film, reduce the inflammation on the surface, and address whatever is degrading the meibomian glands and goblet cells responsible for producing healthy tears. Understanding this paradox matters practically, because a patient who thinks their watery eyes mean they are producing too many tears may avoid artificial tears or other lubricating treatments that could actually help. In reality, supplemental lubrication with preservative-free artificial tears is often recommended alongside glaucoma drops to help stabilize the surface and reduce the reflex tearing cycle.